Phase 3 Tuberculosis, Pulmonary Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Shortened Regimen for Drug-susceptible TB in Children
TuberculosisTuberculosis, PulmonaryMycobacterium Tuberculosis+1 more
Johns Hopkins University860 enrolled9 locationsNCT06253715
Recruiting
Phase 3
Pragmatic Optimized Rifampicin Trial
Tuberculosis, Pulmonary
Radboud University Medical Center164 enrolled2 locationsNCT06057519
Recruiting
Phase 2Phase 3
Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR
University of California, San Francisco400 enrolled6 locationsNCT06441006
Recruiting
Phase 2Phase 3
Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Tuberculosis, Pulmonary
University of Cape Town220 enrolled1 locationNCT04147286
Recruiting
Phase 2Phase 3
Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)
Tuberculosis, Pulmonary
Huashan Hospital2,442 enrolled6 locationsNCT05401071